A new study by researchers in Singapore and China indicates that shorter antibiotic courses are reasonable for children with uncomplicated urinary tract infections (UTIs).
In a review and meta-analysis published yesterday in Clinical Microbiology and Infection, the researchers analyzed data from 13 randomized clinical trials (RCTs) that compared shorter-course (two to five days) versus longer-course (seven or more days) antibiotic therapy in children with uncomplicated UTIs.
While most guidelines recommend anywhere from seven to 14 days of antibiotics, concerns about antibiotic overuse in children and observations by clinicians that many children with UTIs achieve clinical stability within three days of treatment have raised questions about those recommendations.
“A key area of debate concerns the optimal duration of antibiotic therapy, particularly whether treatment should be discontinued upon symptom resolution or continued to complete the full guideline-recommended course,” the study authors write.
Analysis of the 13 RCTs, which involved more than 2,000 children (mean age, 5.9 years), found moderate- to high-certainty evidence that shorter-course antibiotic therapy “probably” results in in no difference in relapse rate (risk ratio [RR], 1.08) or reinfection rate (RR, 0.63) compared with longer-course therapy.
Low-certainty evidence showed that shorter-course therapy “may result in little or no difference” in bacteriologic cure rate (RR, 0.96) or clinical cure rate (RR, 0.99), while moderate-certainty evidence demonstrated no difference in adverse-event rates (RR, 0.93).
Limited data on infants, kids with recurrent UTIs
“A shorter-course regimen, with appropriate follow-up, may be considered a reasonable option following a thorough discussion of the potential risks and benefits in clinical practice for children with acute uncomplicated UTI,” the authors conclude.
The researchers say the findings are in line with other recently published meta-analyses. But they note that because of limited data, it’s uncertain if the findings can be applied to infants aged 2 months to 2 years, children with a history of recurrent UTIs, and those who have UTIs with fever. Further research to determine the optimal antibiotic duration for these subgroups will be needed, they add.